|
| 37921664 | Cardiovascular magnetic resonance imaging for sequential assessment of cardiac fibrosis in mice: technical advancements and reverse translation. | Am J Physiol Heart Circ Physiol | 2024 |
| 37987775 | A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology. | J Mol Med (Berl) | 2024 |
| 38054572 | Deletion of the muscle enriched lncRNA Oip5os1 induces atrial dysfunction in male mice with diabetes. | Physiol Rep | 2023 |
| 34902541 | Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities. | Cell Signal | 2022 |
| 35616058 | Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity. | Circulation | 2022 |
| 36231079 | In Vivo Inhibition of miR-34a Modestly Limits Cardiac Enlargement and Fibrosis in a Mouse Model with Established Type 1 Diabetes-Induced Cardiomyopathy, but Does Not Improve Diastolic Function. | Cells | 2022 |
| 33246162 | IGF1-PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity. | J Sport Health Sci | 2021 |
| 33495398 | Correction for McMullen et al., "Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy". | Mol Cell Biol | 2021 |
| 33861516 | Proteome characterisation of extracellular vesicles isolated from heart. | Proteomics | 2021 |
| 33804032 | Old Drug, New Trick: Tilorone, a Broad-Spectrum Antiviral Drug as a Potential Anti-Fibrotic Therapeutic for the Diseased Heart. | Pharmaceuticals (Basel) | 2021 |
| 33577435 | FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K. | Am J Physiol Heart Circ Physiol | 2021 |
| 34958085 | A Step-By-Step Method to Detect Neutralizing Antibodies Against AAV using a Colorimetric Cell-Based Assay. | J Vis Exp | 2021 |
| 34647038 | A protocol for rapid and parallel isolation of myocytes and non-myocytes from multiple mouse hearts. | STAR Protoc | 2021 |
| 34831402 | Overexpression of Heat Shock Protein 70 Improves Cardiac Remodeling and Survival in Protein Phosphatase 2A-Expressing Transgenic Mice with Chronic Heart Failure. | Cells | 2021 |
| 34246805 | Tissue-specific expression of Cas9 has no impact on whole-body metabolism in four transgenic mouse lines. | Mol Metab | 2021 |
| 34142046 | Loss of the long non-coding RNA OIP5-AS1 exacerbates heart failure in a sex-specific manner. | iScience | 2021 |
| 34082914 | Prevention of Pathological Atrial Remodeling and Atrial Fibrillation: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2021 |
| 33115826 | Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes. | Diabetes | 2021 |
| 32142359 | Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes. | Am J Physiol Heart Circ Physiol | 2020 |
| 32499698 | Andersen-Tawil Syndrome Is Associated With Impaired PIP<sub>2</sub> Regulation of the Potassium Channel Kir2.1. | Front Pharmacol | 2020 |
| 32172307 | Clusterin is regulated by IGF1-PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicity. | Arch Toxicol | 2020 |
| 30387702 | Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling. | Am J Physiol Heart Circ Physiol | 2019 |
| 31347916 | CORP: Practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolism. | Am J Physiol Heart Circ Physiol | 2019 |
| 30846681 | Author Correction: PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart. | Exp Mol Med | 2019 |
| 30596969 | Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2. | Cardiovasc Res | 2019 |
| 30571279 | Noncoding RNAs regulating cardiac muscle mass. | J Appl Physiol (1985) | 2019 |
| 30537346 | Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development. | Immunol Cell Biol | 2019 |
| 28901789 | Cardiac side effects of bruton tyrosine kinase (BTK) inhibitors. | Leuk Lymphoma | 2018 |
| 30050113 | PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart. | Exp Mol Med | 2018 |
| 30184508 | Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets. | Cell Rep | 2018 |
| 29844319 | Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure. | Sci Rep | 2018 |
| 30298011 | Generation of MicroRNA-34 Sponges and Tough Decoys for the Heart: Developments and Challenges. | Front Pharmacol | 2018 |
| 29703647 | Adeno-Associated Virus Gene Therapy: Translational Progress and Future Prospects in the Treatment of Heart Failure. | Heart Lung Circ | 2018 |
| 29424570 | Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β<sub>2</sub>-adrenoceptor overexpression. | Am J Physiol Heart Circ Physiol | 2018 |
| 29496356 | Standing up to the cardiometabolic consequences of hematological cancers. | Blood Rev | 2018 |
| 29358507 | Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling. | Clin Sci (Lond) | 2018 |
| 29540469 | Divergent Effects of PKC (Protein Kinase C) α in the Human and Animal Heart? Therapeutic Implications for PKC Inhibitors in Cardiac Patients. | Circ Genom Precis Med | 2018 |
| 29677464 | Improving the quality of preclinical research echocardiography: observations, training, and guidelines for measurement. | Am J Physiol Heart Circ Physiol | 2018 |
| 29351515 | Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts. | Physiol Rev | 2018 |
| 29217479 | Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies. | Biochim Biophys Acta Mol Cell Biol Lipids | 2018 |
| 27124358 | Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases. | RNA Biol | 2017 |
| 28487469 | Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction. | Clin Sci (Lond) | 2017 |
| 28343149 | β-Adrenergic Stimulation Induces Histone Deacetylase 5 (HDAC5) Nuclear Accumulation in Cardiomyocytes by B55α-PP2A-Mediated Dephosphorylation. | J Am Heart Assoc | 2017 |
| 29033140 | The Interplay of Protein Coding and Non-Coding RNAs (circRNAs, lncRNAs) During Cardiac Differentiation. | EBioMedicine | 2017 |
| 29098623 | The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection. | Adv Exp Med Biol | 2017 |
| 26729888 | Let's keep running⿦ exercise, basic science and the knowledge gaps. | Br J Sports Med | 2016 |
| 28149909 | Therapeutic potential of targeting microRNAs to regulate cardiac fibrosis: miR-433 a new fibrotic player. | Ann Transl Med | 2016 |
| 27845575 | HSP70: therapeutic potential in acute and chronic cardiac disease settings. | Future Med Chem | 2016 |
| 27815509 | Long non-coding RNAs (lncRNAs) in skeletal and cardiac muscle: potential therapeutic and diagnostic targets? | Clin Sci (Lond) | 2016 |
| 27692221 | Molecular Aspects of Exercise-induced Cardiac Remodeling. | Cardiol Clin | 2016 |